Siren, L.L.C. Ovid Therapeutics Inc. Transaction History
Siren, L.L.C.
- $2.26 Trillion
- Q4 2024
A detailed history of Siren, L.L.C. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Siren, L.L.C. holds 2,850,000 shares of OVID stock, worth $1.77 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
2,850,000
Previous 2,850,000
-0.0%
Holding current value
$1.77 Million
Previous $3.36 Billion
20.87%
% of portfolio
0.12%
Previous 0.17%
Shares
1 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
40.7MCall Options Held
2.4KPut Options Held
200-
Rubric Capital Management LP New York, NY5.32MShares$3.3 Million0.08% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$2.48 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.39 Million0.13% of portfolio
-
Madison Avenue Partners, LP New York, NY3.72MShares$2.31 Million0.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.15MShares$1.95 Million0.0% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $43.7M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...